Article and Video CATEGORIES

Cancer Journey

Search By

ABOUT
Denise Brock

Denise has over 30 years of varying experience in the healthcare arena.  In August 2009 she joined The Global Resource for Advancing Cancer Education as one of its first employees.  She has grown with the organization and now oversees the operational movement of programs, efficiency, and effectiveness within the organization, as well as the daily processes and functions.  

 

Join us September 12, 2020 for the rescheduled Targeted Therapies Patient Forum
Please read the information below regarding the 2020 Targeted Therapies Patient Forum reschedule due to COVID-19.
Author
Denise Brock
Image

Join us for the rescheduled LIVE ONLINE Targeted Therapies Forum 

September 12, 2020       Register Now!


 
The health and safety of our staff, faculty and patient community is our highest priority. Therefore, the Global Resource for Advancing Cancer Education had made the difficult decision to postpone our annual Targeted Therapies Forum, originally scheduled for March 28 in Boston, until early fall due to the current COVID-19 outbreak.  We are pleased to confirm the LIVE ONLINE Targeted Therapies Forum will be September 12, 2020.
 

Due to travel bans and health risk concerns, rescheduling this event will enable us to ensure an experience that all participants expect and deserve in a safe environment. We are pleased with and believe you will agree our online platform will be user friendly and a great experience for all of us. 

We are eager to have you join us for this highly anticipated annual livestreamed event which features the top oncologists in their field presenting the most current and emerging information in targeted therapies and answering patient questions in real time. The rescheduled event will be September 12, 2020.  More details will be forthcoming, and your registration will automatically be applied to the rescheduled event; there is no need to re-register. 

Registration remains open at this time and as more information becomes available we will notify you.  

The latest information about our Targeted Therapies Forum will always be available at www.cancergrace.org

If you have any questions regarding your registration, please email us at info@cancerGRACE.org

We look forward to having you join us in the fall. Until then, stay safe and healthy!

 


Join GRACE Live ONLINE September 12, 2020

Register Below for the GRACE 2020 Targeted Therapies Patient Forum!

This event will be held LIVE ONLINE

For Details - Please View the full Agenda and the Faculty Information for more information! 

Register Now!

Video Language

Next Previous link

Previous PostNext Post

Related Content

Article
Advance directives are a powerful way to take control of healthcare choices. These documents allow you to outline preferences for medical care and specify end-of-life wishes. These documents can also be a way to appoint loved ones who you would like to help with these decisions, such as a healthcare proxy (someone to make decisions on your behalf, if you cannot). As cancer treatments can involve aggressive treatments and/or complex medical management, having advance directives ensures that your desires regarding treatment options and end-of-life care are clearly communicated. 
Image
2024-25 patient perspectives header
Article
Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial.  We want to hear from you!
Image
Foro de Pacientes de Terapias Dirigidas de Cáncer de Pulmón
Video
¡El vídeo completo bajo demanda está disponible para verlo!

Forum Discussions

Hi elysianfields and welcome to Grace.  I'm sorry to hear about your father's progression. 

 

Unfortunately, lepto remains a difficult area to treat.  Recently FDA approved the combo Lazertinib and Amivantamab...

Hello Janine, thank you for your reply.

Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...

Hi elysianfields,

 

That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...

Recent Comments

JOIN THE CONVERSATION
I could not find any info on…
By JanineT GRACE … on
Hi elysianfields,

 

That's…
By JanineT GRACE … on
Hello Janine, thank you for…
By elysianfields on
EGFR
By happybluesun on